179 related articles for article (PubMed ID: 36850003)
41. Recent approaches to gout drug discovery: an update.
Otani N; Ouchi M; Kudo H; Tsuruoka S; Hisatome I; Anzai N
Expert Opin Drug Discov; 2020 Aug; 15(8):943-954. PubMed ID: 32329387
[TBL] [Abstract][Full Text] [Related]
42. Crystals of monosodium urate monohydrate enhance lipopolysaccharide-induced release of interleukin 1 beta by mononuclear cells through a caspase 1-mediated process.
Giamarellos-Bourboulis EJ; Mouktaroudi M; Bodar E; van der Ven J; Kullberg BJ; Netea MG; van der Meer JW
Ann Rheum Dis; 2009 Feb; 68(2):273-8. PubMed ID: 18390571
[TBL] [Abstract][Full Text] [Related]
43. Relationship between serum allantoin and urate in healthy subjects and effects of benzbromarone in gout patients.
Kurajoh M; Koyama H; Shoji T; Sumida C; Yamamoto A; Tsutsumi Z; Moriwaki Y; Yamamoto T; Koga M
Int J Clin Pharmacol Ther; 2012 Apr; 50(4):265-71. PubMed ID: 22456297
[TBL] [Abstract][Full Text] [Related]
44. Sugar-sweetened beverages, urate, gout and genetic interaction.
Merriman TR; Dalbeth N; Johnson RJ
Pac Health Dialog; 2014 Mar; 20(1):31-8. PubMed ID: 25928993
[TBL] [Abstract][Full Text] [Related]
45. Activation Status of NLRP3 Inflammasome in Peripheral Blood Mononuclear Cells From Patients With Gout Flare.
Amezcua-Castillo LM; Juárez-Vicuña Y; Márquez-Velasco R; Amezcua-Guerra LM
J Clin Rheumatol; 2020 Oct; 26(7S Suppl 2):S208-S212. PubMed ID: 32332275
[TBL] [Abstract][Full Text] [Related]
46. Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout.
Toyoda Y; Pavelcová K; Bohatá J; Ješina P; Kubota Y; Suzuki H; Takada T; Stiburkova B
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669292
[TBL] [Abstract][Full Text] [Related]
47. The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion.
Hoque KM; Dixon EE; Lewis RM; Allan J; Gamble GD; Phipps-Green AJ; Halperin Kuhns VL; Horne AM; Stamp LK; Merriman TR; Dalbeth N; Woodward OM
Nat Commun; 2020 Jun; 11(1):2767. PubMed ID: 32488095
[TBL] [Abstract][Full Text] [Related]
48. Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: an exploratory, randomized, multicenter, double-blind, placebo-controlled, parallel-group early phase 2 study.
Hosoya T; Sano T; Sasaki T; Fushimi M; Ohashi T
Clin Exp Nephrol; 2020 Mar; 24(Suppl 1):44-52. PubMed ID: 31754882
[TBL] [Abstract][Full Text] [Related]
49. Monosodium urate crystal-induced triggering receptor expressed on myeloid cells 1 is associated with acute gouty inflammation.
Lee J; Lee SY; Lee J; Lee J; Baek S; Lee DG; Kim EK; Lee SH; Cho ML; Kwok SK; Ju JH; Park SH
Rheumatology (Oxford); 2016 Jan; 55(1):156-61. PubMed ID: 26320130
[TBL] [Abstract][Full Text] [Related]
50. Atypical familial juvenile hyperuricemic nephropathy associated with a hepatocyte nuclear factor-1beta gene mutation.
Bingham C; Ellard S; van't Hoff WG; Simmonds HA; Marinaki AM; Badman MK; Winocour PH; Stride A; Lockwood CR; Nicholls AJ; Owen KR; Spyer G; Pearson ER; Hattersley AT
Kidney Int; 2003 May; 63(5):1645-51. PubMed ID: 12675839
[TBL] [Abstract][Full Text] [Related]
51. An update on the genetics of hyperuricaemia and gout.
Major TJ; Dalbeth N; Stahl EA; Merriman TR
Nat Rev Rheumatol; 2018 Jun; 14(6):341-353. PubMed ID: 29740155
[TBL] [Abstract][Full Text] [Related]
52. Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: randomized, multicenter, double-blind, placebo-controlled, parallel-group, confirmatory phase 2 study.
Hosoya T; Sano T; Sasaki T; Fushimi M; Ohashi T
Clin Exp Nephrol; 2020 Mar; 24(Suppl 1):53-61. PubMed ID: 31792640
[TBL] [Abstract][Full Text] [Related]
53. Urate Transporter ABCG2 Function and Asymptomatic Hyperuricemia: A Retrospective Cohort Study of CKD Progression.
Ohashi Y; Kuriyama S; Nakano T; Sekine M; Toyoda Y; Nakayama A; Takada T; Kawamura Y; Nakamura T; Matsuo H; Yokoo T; Ichida K
Am J Kidney Dis; 2023 Feb; 81(2):134-144.e1. PubMed ID: 35810827
[TBL] [Abstract][Full Text] [Related]
54. Pathophysiology of Gout.
Narang RK; Dalbeth N
Semin Nephrol; 2020 Nov; 40(6):550-563. PubMed ID: 33678310
[TBL] [Abstract][Full Text] [Related]
55. Effects of multiple genetic loci on the pathogenesis from serum urate to gout.
Dong Z; Zhou J; Jiang S; Li Y; Zhao D; Yang C; Ma Y; Wang Y; He H; Ji H; Yang Y; Wang X; Xu X; Pang Y; Zou H; Jin L; Wang J
Sci Rep; 2017 Mar; 7():43614. PubMed ID: 28252667
[TBL] [Abstract][Full Text] [Related]
56. Dendrobium officinalis six nostrum ameliorates urate under-excretion and protects renal dysfunction in lipid emulsion-induced hyperuricemic rats.
Chen X; Ge HZ; Lei SS; Jiang ZT; Su J; He X; Zheng X; Wang HY; Yu QX; Li B; Lv GY; Chen SH
Biomed Pharmacother; 2020 Dec; 132():110765. PubMed ID: 33120237
[TBL] [Abstract][Full Text] [Related]
57. Identification of GLUT12/SLC2A12 as a urate transporter that regulates the blood urate level in hyperuricemia model mice.
Toyoda Y; Takada T; Miyata H; Matsuo H; Kassai H; Nakao K; Nakatochi M; Kawamura Y; Shimizu S; Shinomiya N; Ichida K; Hosoyamada M; Aiba A; Suzuki H
Proc Natl Acad Sci U S A; 2020 Aug; 117(31):18175-18177. PubMed ID: 32690690
[TBL] [Abstract][Full Text] [Related]
58. Berberrubine attenuates potassium oxonate- and hypoxanthine-induced hyperuricemia by regulating urate transporters and JAK2/STAT3 signaling pathway.
Lin G; Yu Q; Xu L; Huang Z; Mai L; Jiang L; Su Z; Xie J; Li Y; Liu Y; Lin Z; Chen J
Eur J Pharmacol; 2021 Dec; 912():174592. PubMed ID: 34699754
[TBL] [Abstract][Full Text] [Related]
59. Resveratrol ameliorates gouty inflammation via upregulation of sirtuin 1 to promote autophagy in gout patients.
Yang QB; He YL; Zhong XW; Xie WG; Zhou JG
Inflammopharmacology; 2019 Feb; 27(1):47-56. PubMed ID: 30600470
[TBL] [Abstract][Full Text] [Related]
60. Anti-hyperuricemic effect of Alpinia oxyphylla seed extract by enhancing uric acid excretion in the kidney.
Lee YS; Sung YY; Yuk HJ; Son E; Lee S; Kim JS; Kim DS
Phytomedicine; 2019 Sep; 62():152975. PubMed ID: 31181404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
